Satellite Bio

formerly Satellite Biosciences

Unlocking the full potential of liver cells as medicine

Cambridge, United States · Founded 2019 · $196.5M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$196.5M
Last Round
$95.0M Series BJan 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Satellite Bio is a Cambridge, Massachusetts-based biotech company pioneering tissue therapeutics. Its proprietary off-the-shelf liver therapy delivers functional hepatocytes into the body to engraft and restore liver function. The company raised $110M across seed and Series A rounds and emerged from stealth in 2022. It uses drug-like manufacturing for scalable, cost-effective global distribution.

Summary

Satellite Bio is a Biotech company based in Cambridge, United States, founded in 2019. It has raised $196.5M in total across 3 rounds, most recently a $95.0M Series B round in Jan 2024. Investors include aMoon, Alpha Wave Ventures and Alumni Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2024
$95.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Satellite Bio on Indexed.vc
<a href="https://indexed.vc/companies/satellite-bio"><img src="https://indexed.vc/api/badge/company/satellite-bio" alt="Satellite Bio on Indexed.vc" width="260" height="76" /></a>